Trial NCT01455246

View at ClinicalTrials.gov 
Org. Study IDs: 2059P
Secondary IDs: 2010-019625-34

Last trial update was posted on 2014-10-15

MeSH Interventions

Ceftazidime Daptomycin Meropenem

MeSH Conditions

Ascites Fibrosis Peritonitis

Other Conditions

Cirrhosis Nosocomial Spontaneous Bacterial Peritonitis

Stopping Reasons

Decision of independent monitoring committee after interim analysis: Risk of failure significantly higher in ceftazidime group.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID